Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

A Possible Blood Test for Alzheimer’s Disease

Published: Monday, July 29, 2013
Last Updated: Monday, July 29, 2013
Bookmark and Share
A new blood test can be used to discriminate between people with Alzheimer's disease and healthy controls.

It's hoped the test, described in the open access journal Genome Biology, could one day be used to help diagnose the disease and other degenerative disorders.

Alzheimer's disease, the most common form of dementia, can only be diagnosed with certainty at autopsy, so the hunt is on to find reliable, non-invasive biomarkers for diagnosis in the living. Andreas Keller  and colleagues focused on microRNAs (miRNAs), small non-coding RNA molecules known to influence the way genes are expressed, and which can be found circulating in bodily fluids including blood.

The team, from Saarland University and Siemens Healthcare highlighted and tested a panel of 12 miRNAs, levels of which were found to be different amongst a small sample of Alzheimer's patients and healthy controls. In a much bigger sample, the test reliably distinguished between the two groups.

 Decent biomarkers need to be accurate, sensitive (able to correctly identify people with the disease) and specific (able to correctly pinpoint people without the disease). The new test scores over 90% on all three measures. But whilst the test shows obvious promise, it still needs to be validated for clinical use, and may eventually work best when combined with other standard diagnostic tools, such as imaging, the authors say.

As people with other brain disorders can sometimes show Alzheimer's-like symptoms, the team also looked for the miRNA signature in other patient groups. The test distinguished controls from people with various psychological disorders, such as schizophrenia and depression, with over 95% accuracy, and from patients with other neurodegenerative disorders, such as mild cognitive impairment and Parkinson's disease, with lower accuracy. It also discriminated between  Alzheimer's patients and patients with other neurodegenerative disorders, with an accuracy of around 75%. But by tweaking the miRNAs used in the test, accuracy could be improved.

The work builds on previous studies highlighting the potential of miRNAs as blood-based biomarkers for many diseases, including numerous cancers, and suggests that miRNAs could yield useful biomarkers for various brain disorders. But it also sheds light on the mechanisms underpinning Alzheimer's disease. Two of the miRNAs are known involved in amyloid precursor protein processing, which itself is involved in the formation of plaques, a classic hallmark of Alzheimer's disease.  And many of the miRNAs are believed to influence the growth and shape of neurons in the developing brain.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Imaging Software Could Speed Up Breast Cancer Diagnosis
Researchers use high speed optical microscopy of intact breast tissue specimens to analyze breast tissue.
Friday, August 21, 2015
Leukaemia Drug Could Help Treat Breast Cancer
A drug currently used to treat leukaemia might also help prevent breast cancer from spreading to other parts of the body.
Friday, August 23, 2013
Gene Signature Can Predict Who Will Survive Chemotherapy
An eight gene ‘signature’ can predict length of relapse-free survival after chemotherapy, finds new research in Biomed Central’s open access journal BMC Medicine.
Tuesday, April 16, 2013
Oxygen-Free Energy Designed to Fuel Brain Development Spurs on Growth of Cancer
The metabolic process which fuels the growth of many cancers has its origins in normal brain growth finds a new study published in BioMed Central's open access journal Cancer & Metabolism.
Wednesday, January 23, 2013
Genetic Predictor of Breast Cancer Response to Chemotherapy
Gene expression 'signatures' to measure the susceptibility of tumor cells to chemotherapy.
Friday, May 11, 2012
Cellular 'Glue' Resists Breast Cancer
New research demonstrates that the protein Perp provides a potential new target for future treatment of breast cancer.
Thursday, April 19, 2012
DIMming Cancer Growth - STAT: diindolylmethane Suppresses Ovarian Cancer
New research published in BioMed Central’s open access journal BMC Medicine has looked in detail at the action of DIM and showed that it works by blocking the activation and production of the transcription factor STAT3.
Wednesday, January 25, 2012
Relatives of Melanoma Patients Ignore their Skin Cancer Risk
New research shows that young people in ‘at risk’ group are still ignoring sun safety advice.
Thursday, December 29, 2011
Elevated Hormone Levels Add Up to Increased Breast Cancer Risk
New research found that the risk of breast cancer increased with the high levels of estrogen or testosterone hormones.
Monday, October 24, 2011
Modeling Cancer Using Ecological Principles
New research uses Tilman model of competition between invasive species to study the metastasis of prostate cells into bone.
Tuesday, October 04, 2011
Heart Disease Beats Breast Cancer as the Biggest Killer
Research shows that women with breast cancer died from other causes and that over the length of the study cardiovascular disease was the leading cause of death.
Tuesday, June 21, 2011
C-reactive Protein Levels Predict Breast Cancer Survival Rates
BioMed Central's new research shows that elevated CRP levels are predictive of a poor prognosis for breast cancer sufferers.
Friday, June 03, 2011
Coffee Reduces Breast Cancer Risk
Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor (ER)-negative breast cancer.
Wednesday, June 01, 2011
High Throughput RNAi Assay Optimization Using Adherent Cell Cytometry
Researchers from Harvard Medical School have detailed how adherent cell cytometry can be used as a high throughput-screening tool for the optimization of RNAi assays, accelerating in vitro cell assays and reducing costs.
Tuesday, May 03, 2011
Quantitative miRNA Expression Analysis Using Fluidigm Microfluidics Dynamic Arrays
An article published in the journal BMC Genomics demonstrates how the qPCR-array based microfluidic dynamic array platform can be used in conjunction with multiplexed RT reactions for miRNA gene expression profiling.
Tuesday, April 12, 2011
Scientific News
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Specific Variations in RNA Splicing Linked to Breast Cancer
Researchers have identified cellular changes that may play a role in converting normal breast cells into tumors. Targeting these changes could potentially lead to therapies for some forms of breast cancer.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
Editing Genes to Create HIV Killers
Seattle scientists have managed to genetically transform human cells in the lab from HIV targets to HIV killers, and the technique could have implications for cancer and other diseases.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos